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Kaposi’s sarcoma-associated herpesvirus (KSHV) is a member of the gammaherpesvirus family. KSHV is
the etiologic agent of Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease.
The first open reading frame of the KSHV genome encodes a type 1 transmembrane glycoprotein named K1.
K1 is structurally similar to the B-cell receptor (BCR), and its cytoplasmic tail contains an immunoreceptor
tyrosine-based activation motif that can activate Syk kinase and the phosphatidylinositol 3-kinase (PI3K)/Akt
pathway. Recent evidence suggests that receptor signaling occurs not only at the cell membrane, but from
intracellular compartments as well. We have found that K1 is internalized in a clathrin-dependent manner,
and efficient internalization is coupled to its signaling function. Once internalized, K1 traffics from the early
endosome to the recycling endosome. Interestingly, blocking K1’s activation of Syk and PI3K prevents K1 from
internalizing. We have also found that blocking clathrin-mediated endocytosis prevents downstream signaling
by K1. These results strongly suggest that internalization of K1 is intimately associated with normal signaling.
When K1 internalization was examined in B lymphocytes, we found that K1 cointernalized with the BCR.
Altogether, these results suggest that K1’s signaling function is tightly coupled to its internalization.
Kaposi’s sarcoma (KS)-associated herpesvirus (KSHV) (also
called human herpesvirus 8) is a gammaherpesvirus that was first
identified in KS biopsies (5). KSHV has since been found in all
epidemiological forms of KS (18). Viral DNA has been consis-
tently isolated in AIDS-associated KS and almost all European/
Mediterranean KS (9, 13, 30). KSHV has also been associated
with lymphoproliferative diseases, such as primary effusion lym-
phoma and multicentric Castleman’s disease (44), both of which
are of B-cell origin. The exact mechanism by which KSHV in-
duces transformation has not yet been completely dissected.
The far-left end of the KSHV genome encodes a 46-kDa
transmembrane glycoprotein called K1. This position is equiv-
alent to that of the saimiri transformation protein of herpes-
virus saimiri (32) and the R1 oncogene of rhesus monkey
rhadinovirus (12). K1 is expressed in KS lesions, primary effu-
sion lymphoma cells, and multicentric Castleman’s disease (1,
19, 24, 39). K1 is structurally similar to the B-cell receptor
(BCR). The cytoplasmic tail contains an immunoreceptor ty-
rosine-based activation motif (ITAM), which has been shown
to be capable of activating a signal profile (21, 26) similar to
that activated by the BCR in B lymphocytes (38). The ITAM is
essentially comprised of two SH2 binding motifs. Unlike the
BCR, K1 is constitutively active, possibly due to oligomeriza-
tion via conserved extracellular cysteine residues (21). K1 has
been shown to interact with multiple cellular proteins contain-
ing SH2 domains, including Lyn, Syk, p85, PLC2, RasGAP,
Vav, and Grb2. This interaction is thought to occur through
the phosphorylated SH2 binding motifs that constitute the
ITAM in the C terminus of K1 (25). Furthermore, K1 expres-
sion has also been shown to promote the production and se-
cretion of vascular endothelial growth factor in both epithelial
and endothelial cells and to increase matrix metalloproteinase
9 expression in endothelial cells, all of which is dependent on
the SH2 binding motifs in the K1 cytoplasmic tail (50). Trans-
genic K1 mice develop tumors with features similar to those of
spindle-cell sarcomatoid and malignant plasmablastic lym-
phoma. Moreover, lymphocytes isolated from these transgenic
mice showed constitutive activation of NF-B and Oct-2 and
enhanced Lyn activity (35, 36). Additionally, our laboratory
has previously shown that K1 activates the phosphatidylinositol
3-kinase (PI3K)/Akt pathway in both B cells and endothelial
cells, protecting cells from apoptosis (45, 49).
Activation of cell surface receptors by specific ligands often
results in internalization via clathrin-dependent and -independent
pathways, and internalization of receptors is considered an im-
portant mechanism by which cells control the intensity and
duration of signal transduction. Recent findings indicate that in-
ternalization of receptors can allow signal propagation and am-
plification due to the high order of regulation of the endosome,
using the compartmentalized organization of the endocytic path-
way, going beyond the conventional role of receptor/cargo deg-
radation. Some receptors, such as epidermal growth factor (EGF)
or fibroblast growth factor, can maintain their signaling activities
from within intracellular compartments (3, 41).
In this study, we show that K1 is internalized via clathrin-
mediated endocytosis and that K1’s ability to signal is linked to
its internalization. We further demonstrate that blocking in-
ternalization prevents K1 activation of the PI3K/Akt pathway.
MATERIALS AND METHODS
Reagents and antibodies. LY294002 and amantadine were purchased from
Sigma Chemicals (St. Louis, MO). Piceatannol was purchased from Calbiochem
(La Jolla, CA). Anti-FLAG M1 and M2-Cy3 antibodies were purchased from
Sigma Chemicals. Anti-clathrin–HC antibody was purchased from Santa Cruz
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Biotechnology. Anti-TfR–Alexa 647, anti-immunoglobulin M (IgM)–Alexa 647
and anti-rabbit Alexa 647 were purchased from Molecular Probes, Invitrogen
(Carlsbad, CA). Goat anti-mouse IgG, goat anti-mouse horseradish peroxidase
(HRP), and 1-step ABTS [2,2-azinobis(3-ethylbenzthiazolinesulfonic acid)]
were purchased from Pierce (Rockford, IL). Anti-Akt (S473), anti-Akt (total),
and anti-rabbit HRP were purchased from Cell Signaling (Danvers, MA). Anti-
EEA1–fluorescein isothiocyanate (FITC) was purchased from BD Pharmingen
(Franklin Lakes, NJ).
cDNAs, cell lines, and transfections. pEF-K1WT and pEF-K1ITAM have been
previously described (45). pEF-K1C was constructed by deleting the C terminus
of K1 (Fig. 1). A cDNA encoding the clathrin hub fragment containing an
amino-terminal T7 epitope (MASMTGGQQMG) was provided by J. Trejo
(University of North Carolina). Rab11-green fluorescent protein (GFP) was a
kind gift from Stephen S. G. Ferguson (University of Western Ontario).
HeLa cells stably expressing the tetracycline-regulated chimeric transcription
factor (tetR-VP16) (generously provided by J. Trejo, University of North Caro-
lina) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum, 4.5 mg/ml glucose, 100 units/ml penicillin,
100 g/ml streptomycin, and 100 g/ml G418. The cells were plated at 1.5  105
or 2.5  105 cells per well of 12-, or 6-well plates, respectively, and grown
overnight. The cells were transiently transfected with a total of 0.8 or 2.0 g per
well of 12- or 6-well plates, respectively, of plasmids encoding FLAG-tagged
wild-type (WT) K1 (K1WT) or mutants and either pcDNA vector or GFP fusion
constructs, using Lipofectamine reagent (Invitrogen) according to the manufac-
turer’s instructions. The cells were incubated in complete medium for 48 h prior
to being assayed as indicated below.
DG-75 cells, a human B-cell line that is KSHV negative and Epstein-Barr virus
negative (23), were maintained in RPMI 1640 medium supplemented with 10%
fetal bovine serum, penicillin, and streptomycin. Forty micrograms of pEF-
K1WT, mutants, or empty vector was electroporated in serum-free medium into
8  106 DG-75 cells at 300 V and 950 F.
Internalization assay. To assess the internalization of receptors, HeLa cells
transiently expressing similar amounts of FLAG-K1 (WT or mutant proteins)
were incubated with the calcium-dependent M1 anti-FLAG antibody for 1 h at
4°C. Under these conditions, only receptors present on the cell surface bind
antibody. The cells were washed and incubated for various times at 37°C, allow-
ing the M1 anti-FLAG-bound K1 protein to internalize. The remaining surface-
bound antibody was then removed by three washes with phosphate-buffered
saline (PBS) (Ca2 and Mg2 free) containing 0.04% EDTA for 5 min at 4°C.
The cells were lysed in Triton lysis buffer (50 mM Tris-HCl, pH 7.4, 100 mM
NaCl, 5 mM EDTA, 3% bovine serum albumin [BSA], and 1% Triton X-100).
The amount of internalized anti-FLAG antibody in each cell lysate was then
determined by sandwich enzyme-linked immunosorbent assay (ELISA). Briefly,
96-well plates (Greiner Bio-one; catalog no. 655061) were coated with 1 g/well
goat anti-mouse antibody (Pierce) in 0.1 ml of PBS overnight at 4°C. Each well
was incubated with 0.2 ml of 3% BSA in PBS for 3 h to block nonspecific binding.
Cellular lysates were applied to the plates, and the samples were incubated for
3 h at room temperature, followed by three washes with PBS. Next, 0.5 g of
HRP-coupled goat anti-mouse antibody in 0.1 ml of PBS containing 3% BSA was
added to each well. After five washes in PBS, 0.2 ml of HRP substrate (One Step
ABTS solution; Pierce) was added to each well. HRP activity was determined by
measuring the absorbance at 405 nm using a Fluostar-Optima microplate spec-
FIG. 1. Internalization of K1 in HeLa cells. (A) Diagram of the amino acids in the C termini of K1 and mutants. The ITAM is highlighted.
(B) Transfected cells were surface labeled with M1 anti-FLAG antibody at 4°C for 1 h, washed, and incubated for the times indicated at 37°C.
Antibody remaining on the surface was stripped off, and the cells were lysed. Internalized antibody was quantified by ELISA. The data are
expressed as a percentage of the initial amount of antibody bound to the cell surface at 0 min at 4°C. The error bars indicate standard deviations.
(C) Endocytosis of K1 in a biotin endocytosis assay. HeLa cells were transfected with K1 and mutant expression plasmids as indicated above each
gel. The samples were processed for the biotinylation endocytosis assay as described in Materials and Methods. The biotinylated proteins were
internalized by transferring the cells to 37°C for 10 and 30 min. The  and  symbols indicate presence and absence of glutathione (GSH)
treatment. The cells were then lysed, and all biotinylated proteins were immunoprecipitated (IP) using streptavidin beads. FLAG-K1 was detected
in cell surface and intracellular pools by immunoblotting. The arrows indicate K1-specific bands. The asterisks denote nonspecific bands. (D) The
same samples as in panel C, representing 1% of the input sample before immunoprecipitation.
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trophotometer (BMG Laboratories). To determine the amount of antibody
initially bound to the surface, lysates were prepared from cells washed in PBS
without EDTA.
Cell surface biotinylation and endocytosis assay. HeLa cells were transfected
with WT or mutant K1 expression plasmids as described above. Forty-eight hours
posttransfection, the cells were incubated with 1.5 mg/ml of sulfosuccinimidyl
2-(biotinamido) ethyl-dithioproprionate (sulfo-NHS-SS-biotin) (Pierce Chemi-
cal Company) at 4°C for 1 h and washed with 15 mM glycine in PBS to quench
any free sulfo-NHS-SS-biotin. This was followed by several washes with PBS. To
measure cell surface biotinylated proteins, the cells were then lysed in 0.5 ml of
RIPA buffer (20 mm Tris-HCl, pH 7.4, with 150 mm NaCl, 0.1% sodium dodecyl
sulfate [SDS], 1% Triton X-100, 1% deoxycholate, 5 mM EDTA) containing
protease inhibitors. To measure internalized biotinylated proteins, PBS was
replaced with complete DMEM at 37°C for 10 and 30 min. The cells were washed
twice for 30 min each time in glutathione stripping solution (60 mM glutathione
and 0.83 mM NaCl, with 0.83 mM NaOH and 1% BSA added before use) at 4°C
to remove all cell surface biotin groups. The remaining biotinylated proteins that
were endocytosed were sequestered inside the cell and were therefore protected
from glutathione stripping. The cell extracts were centrifuged to remove cell
debris. The supernatant was incubated with streptavidin beads (Sigma Chemical
Company) to collect bound, biotinylated proteins. These samples were then
analyzed by SDS-polyacrylamide gel electrophoresis (PAGE), and Western blots
were performed to identify K1-FLAG fusion proteins.
Immunofluorescence confocal microscopy. HeLa cells plated on collagen-
coated glass bottom dishes (MatTek, Ashland, MA) or DG-75 cells in suspension
were transfected with FLAG-tagged WT or mutant K1 plasmids, as described
above. Forty-eight hours posttransfection, the cells were preincubated with rab-
bit polyclonal anti-FLAG–Cy3 antibody for 1 h at 4°C to label K1 proteins
expressed on the cell surface. The cells were washed and incubated for various
times at 37°C. The cells were fixed and processed for confocal microscopy.
Briefly, the cells were fixed in 2% paraformaldehyde and permeabilized with
100% methanol. The cells were blocked with 5% normal goat serum. Colocal-
ization of K1 with subcellular structures was assessed by incubating permeabil-
ized cells with antibody for 1 h at 25°C, followed by species-specific fluorophore-
conjugated secondary antibodies and imaging using an Olympus FV500 confocal
laser scanning microscope.
Amantadine and hypertonic treatments. Clathrin-mediated endocytosis was
inhibited using amantadine (2 mM amantadine in DMEM with 1% BSA) or
hypertonic medium (20% sucrose in DMEM with 1% BSA) for 30 min as
described previously (16, 34) and assayed as indicated below.
Western blot assays. To detect Akt phosphorylation, transfected HeLa cells
were serum starved for 24 h; the cells were harvested and lysed in RIPA buffer
containing protease and phosphatase inhibitors. One hundred micrograms of
each protein sample was subjected to SDS-PAGE, transferred to a nitrocellulose
membrane, and probed with anti-Akt–Ser473 (Cell Signal). After detection, the
membranes were stripped and reprobed using Akt (total) antibody (Cell Signal).
RESULTS
Rate of K1 internalization. In order to determine how sur-
face expression of K1 is regulated, we first compared the in-
ternalization rates of K1WT, a K1ITAM mutant in which both
tyrosines present in the two SH2 binding motifs had been
mutated to phenlyalanines (45), and a mutant of K1 in which
the entire carboxyl terminus had been deleted, K1C (Fig. 1A).
HeLa cells were chosen for endocytosis assays, since they have
a larger cytoplasmic compartment than B cells and are easy to
transfect. The cells were transiently transfected with either
FLAG-tagged K1WT, FLAG-tagged K1ITAM, or FLAG-
tagged K1C for 48 h and then labeled with the calcium-
dependent M1-FLAG antibody for 1 h at 4°C. The cells were
washed to remove unbound antibody and incubated at 37°C for
various times. After incubation, the remaining surface-bound
calcium-sensitive M1-FLAG antibody was stripped using an
EDTA/PBS solution. The cells were lysed, and the amount of
internalized M1-FLAG was quantified by a FLAG ELISA. For
K1WT, after 10 min at 37°C, 	40% of the receptor had been
internalized and appeared to reach a steady-state level of in-
ternalization. There was a slight increase in internalized K1 to
	60% after 80 min at 37°C (Fig. 1B). For the K1ITAM mu-
tant, 	20% of receptor had been internalized by 10 min, and
this appeared to be a steady-state level. After 10 min, approx-
imately 10% of K1C surface receptor had been internalized,
reaching 	20% internalization after 80 min at 37°C (Fig. 1B.)
These results suggest that elements in the C terminus of K1 are
involved in internalization, allowing K1WT to internalize most
efficiently.
To confirm that K1 internalization is not dependent on an-
tibody cross-linking, cell surface biotinylation and internaliza-
tion of K1 and the mutants were analyzed (Fig. 1C). We used
a biotin endocytosis assay that employed the disulfide-linked
NHS-SS-biotin, which permits cleavage of any biotin from the
cell surface with glutathione after the 37°C endocytosis step (2,
4, 33, 51). Internalization of biotinylated glycoprotein protects
the biotin from cleavage. The biotinylated proteins were then
immunoprecipitated with streptavidin-conjugated beads and
subjected to SDS-PAGE analysis. Membranes were then
probed with antibody specific to the N-terminal FLAG
epitopes on each construct. The zero-minute lane showed total
cell surface biotinylation of K1 proteins before the glutathione
cleavage step. The zero-minute-minus lane indicated that the
cells were not returned to 37°C and were instead immediately
treated with glutathione; the absence of K1-specific bands
demonstrated that the cleavage step removed all remaining cell
surface biotin to an undetectable level. For the 10-min-plus
and 30-min-plus lanes, cells were incubated at 37°C for the
indicated times before the cleavage step. Thus, if K1were in-
ternalized, a band would be detectable in these lanes. As can
be seen in Fig. 1C, K1WT internalization was detectable by 10
min after incubation at 37°C and continued after 30 min at
37°C. However, for the two mutants, K1ITAM and K1C, no
specific bands appeared at the times tested, indicating that
neither of the two mutants was protected from cleavage by
glutathione, since they were not endocytosed. The banding
pattern seen for the K1 constructs is typical, showing a major
band at 46 kDa and larger bands running at 100, 150, and 200
kDa, most likely due to oligomerization through extracellular
disulfide bonds (20, 21, 27). Input levels of biotinylated pro-
teins are also shown (Fig. 1D). Before immunoprecipitations
were performed, a fraction of the lysate from each sample was
removed and subjected to SDS-PAGE analysis. Membranes
were probed with the same antibody as in Fig. 1C.
Confocal microscopy analysis of HeLa cells transiently trans-
fected with the WT and mutant K1 constructs supported our
ELISA data. Cells transfected with FLAG-tagged K1WT,
FLAG-tagged K1ITAM, or FLAG-tagged K1C were labeled
with an anti-FLAG–CY3 antibody, washed, and incubated for
various times at 37°C. After incubation, the cells were fixed and
analyzed by confocal microscopy. After 20 min of incubation,
K1WT localized predominantly to endocytic-like structures
(Fig. 2). In contrast, K1ITAM and K1C mutants were main-
tained predominantly at the surface at both 20 min and 60 min,
suggesting that their internalization was severely compro-
mised.
We next determined whether K1 was recycled after being
endocytosed. EEA1 served as a marker of early endosomes,
and Rab11 was used as a marker for recycling endosomes.
HeLa cells were labeled for K1 surface expression as described
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above and incubated for 20 min at 37°C. Permeabilized cells
were labeled with anti-EEA1–FITC. EEA1 is a Rab5 effector
protein associated with the cytoplasmic side of early endo-
somes (6). As can be seen in Fig. 3A, K1WT colocalized with
EEA1, which indicated that K1 trafficked to the early endo-
some. The majority of K1ITAM and K1C remained on the
surfaces of the cells.
We also coexpressed K1 with Rab11-GFP. Rab11 has been
shown to coordinate traffic through the recycling endosome
(47). Our confocal analysis revealed that K1WT appeared to
traffic to the recycling endosome, as indicated by colocalization
with Rab11-GFP after incubation at 37°C for 90 min. Con-
versely, K1ITAM and K1C did not appear to colocalize with
Rab11 (Fig. 3B).
K1 is internalized in a clathrin-dependent manner. We next
investigated whether K1 is internalized through a clathrin-
dependent pathway. We first analyzed the colocalization of
K1WT and endogenous clathrin. HeLa cells were transfected
with WT FLAG-K1 expression plasmids and were incubated
with anti-FLAG–Cy3 at 4°C to label K1 on the cell surface.
The cells were placed at 37°C for 5 min, fixed, permeabilized,
and labeled with anti-clathrin–HC–FITC antibody, which
stains the clathrin heavy chain. The cells were examined by
confocal microscopy. The staining was performed 5 min after
incubation of the cells at 37°C. Although the majority of K1
remained on the cell surface, there was internalization of K1
that appeared to colocalize with clathrin (Fig. 4A). We next
looked at the effect of a dominant-negative clathrin hub. The
hub is the C-terminal third of the clathrin heavy chain (29) and
has been shown to act as a dominant-negative clathrin inhibitor
by competing for light-chain binding (28). Cells were tran-
siently transfected as described above with the addition of an
expression vector encoding the clathrin hub fragment with an
amino-terminal T7 epitope. The cells were labeled with anti-
FLAG–Cy3 at 4°C and moved to 37°C for 20 min. The cells
were then fixed and permeabilized. Cells expressing the clath-
rin hub mutant were identified by costaining them for the T7
epitope. Antibody to the T7 epitope labeled the entire cyto-
plasm, as previously described (46). We found that cells that
expressed the clathrin hub showed decreased internalization of
K1, with K1 primarily localized to the cytoplasmic membrane
after 20 min at 37°C (Fig. 4B), further supporting the hypoth-
esis that K1 is internalized in a clathrin-dependent manner.
We examined the effects of clathrin inhibitors on K1 inter-
nalization. Amantadine is a drug that inhibits clathrin-coated-
pit invagination at the plasma membrane (34). Cells transiently
transfected with either FLAG-tagged K1WT, FLAG-tagged
FIG. 2. Confocal analysis of K1 internalization. WT and mutant
K1-FLAG expression plasmids were transfected into HeLa cells.
Forty-eight hours posttransfection, the transfected cells were surface
labeled with anti-Flag–Cy3 antibody at 4°C for 1 h and then transferred
to 37°C for 20 or 60 min. The cells were fixed and analyzed by confocal
microscopy.
FIG. 3. Subcellular trafficking of K1. (A) K1-expressing HeLa cells were incubated with anti-FLAG–CY3 for 1 h at 4°C. Bound receptors were
allowed to internalize for 20 min at 37°C and subsequently labeled with FITC-labeled anti-EEA1 antibody. (B) HeLa cells were cotransfected with
K1 expression vectors and a Rab11-GFP expression vector. The cells were surface labeled with anti-FLAG–Cy3 for 1 h at 4°C. The cells were
incubated at 37°C for 90 min. The cells were fixed and imaged by confocal microscopy.
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K1ITAM, or FLAG-tagged K1C were stained as described
above and incubated in the presence or absence of amantadine
for 20 min at 37°C. The cells were then assayed for internalized
K1 protein via ELISA. In K1WT cells, internalization was sub-
stantially inhibited by amantadine (Fig. 5A), while both mu-
tants were less affected by clathrin inhibition. Conversely, K1
internalization was not inhibited by the caveolin inhibitor fili-
pin (data not shown). Shown in Fig. 5B are confocal data
supporting inhibition of K1 internalization by amantadine. K1-
expressing cells were stained as described above. As a positive
control, we also labeled the transferrin receptor (TfR) using
anti-TfR–Alexa 647 antibody (Molecular Probes). The TfR has
been well studied and constitutively cycles between the plasma
membrane, early endosomes, and recycling endosomes, and it
has served as a classic system for the study of clathrin-mediated
endocytosis (8). Amantadine prevented the majority of K1
protein from internalizing, as well as preventing TfR internal-
ization (Fig. 5B).
K1 endocytosis and signaling are coupled. Recent work has
shown regulation of receptor signaling as a function of recep-
tor internalization (3, 40–42). Subcellular localization can de-
termine which effector molecules couple to activated receptors
and the relative strengths of different signaling pathways. To
that end, we wanted to determine if known signaling molecules
activated by K1 are cointernalized and/or colocalized intracel-
lularly. Conner and Schmid had previously shown that K1 can
activate the PI3K signaling pathway in B cells and endothelial
cells (8). Here, we examined whether K1 colocalized with the
p85 subunit of PI3K. HeLa cells were transfected with a WT
K1 FLAG expression plasmid. Forty-eight hours posttransfec-
tion, the cells were surface labeled with anti-FLAG–Cy3 to
detect K1. The cells were either left on ice (Fig. 6A; t 
 0) or
moved to 37°C for 5 min (Fig. 6A; t 
 5). Next, the cells were
placed on ice, rinsed with cold PBS, and fixed. After perme-
abilization, the cells were incubated with anti-p85 primary an-
tibody, followed by a FITC-conjugated secondary antibody to
detect the p85 subunit of PI3K, and examined by confocal
microscopy. K1WT and the p85 subunit of PI3K appeared to
colocalize very well at t 
 0, and there was also colocalization
of K1 and p85 at t 
 5 (Fig. 6A). We also analyzed K1 colo-
calization with p85 without prelabeling K1 surface molecules
to get a better sense of their intracellular interaction. HeLa
cells were transfected with a K1WT-FLAG expression plasmid.
Forty-eight hours posttransfection, the cells were permeabil-
ized and stained for FLAG-K1 and p85. As can be seen in Fig.
6B, K1 also appeared to colocalize with p85 intracellularly.
To further delineate the relationship between signaling and
internalization, we utilized specific chemical inhibitors of ki-
nases activated by K1, such as PI3K and Syk (8), and deter-
mined their effects on K1 internalization by both ELISA and
confocal microscopy. LY294002 is an inhibitor of PI3K, and
piceatannol is a Syk kinase inhibitor. HeLa cells were trans-
fected with K1 and K1 mutant expression vectors and pro-
cessed as described above. Additionally, cell surface-expressed
TfR was labeled using anti-TfR–Alexa 647 antibody for con-
focal studies. LY294002 was added during subsequent 37°C
incubations. As determined by ELISA, LY294002 inhibited
K1WT internalization by over twofold after 20 min but had little
or no effect on the K1ITAM or K1C protein (Fig. 7A). This
was further corroborated by confocal data showing little or no
K1WT internalization when cells were treated with LY294002
(Fig. 7B). In contrast, the TfR was internalized in an efficient
manner.
K1 has also been shown to activate Syk kinase (25). We next
tested whether piceatannol, an inhibitor of Syk kinase, affected
K1 endocytosis. We found that piceatannol also inhibited K1
internalization, although not to the same extent as seen with
LY294002 (Fig. 8A), resulting in approximately 50% decrease
after the cells were incubated for 20 min at 37°C in the pres-
ence of the drug. Confocal data also supported this, showing
that the majority of K1 remained on the surface in the pres-
ence of piceatannol (Fig. 8B). The two K1 mutants, K1ITAM
and K1C, were retained on the surface regardless of drug
treatment.
Inhibition of endocytosis dampens signaling by K1. To ex-
amine whether K1 endocytosis and trafficking are important
for controlling the signaling pathways and cellular responses to
K1, we inhibited endocytosis by treating cells with amantadine
or hypertonic medium. Hypertonic medium has been shown to
inhibit clathrin-mediated endocytosis (16). HeLa cells were
transiently transfected as described above. Twenty-four hours
posttransfection, the cells were serum starved for an additional
24 h. The cells were pretreated for 30 min in fresh medium
FIG. 4. K1 is internalized in a clathrin-dependent manner. (A) Co-
localization of K1WT with endogenous clathrin-HC. K1-expressing
cells were surface labeled with anti-FLAG–Cy3 for 1 h at 4°C. After
incubation at 37°C for 5 min, the cells were fixed and immunostained
for clathrin-HC. Bound antibodies were visualized with the use of
secondary antibody conjugated to FITC. The boxed region indicates
the magnified area (Zoom). (B) HeLa cells were cotransfected with K1
and T7-Hub. The cells were labeled with an anti-FLAG–Cy3 antibody
at 4°C, incubated at 37°C for 20 min, and then processed as described
in the text. Cells expressing the clathrin hub mutant were identified by
costaining them for the T7 epitope. A phase-contrast image of the cell
is on the right.
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containing 2 mM amantadine or 20% sucrose. The cells were
harvested, and the lysates were separated by SDS-PAGE, blot-
ted onto membranes, and probed with anti-phospho-Akt
(S473). As shown in Fig. 9, expression of K1WT increased Akt
phosphorylation in these cells, while K1ITAM and K1C did
not induce Akt phosphorylation. Treatment with the endocy-
tosis inhibitors, amantadine and sucrose, dramatically de-
creased Akt phosphorylation in K1WT-expressing cells (Fig. 9).
K1 internalization in B cells. We next analyzed K1 internal-
ization in DG75 B cells, which are KSHV negative. Since
KSHV infects B lymphocytes, we wanted to determine if K1
cointernalized with the BCR. Cells were electroporated with
K1 and mutant expression vectors as described in Materials
and Methods. Twenty-four hours posttransfection, the cells
were surface labeled for K1 using anti-FLAG–CY3 antibody
and for IgM using anti-IgM–Alexa 647 antibody. After un-
bound antibody was rinsed away, the cells were incubated at
37°C for the indicated times, fixed, and analyzed by confocal
microscopy. As can be seen in Fig. 10A, K1 and IgM colocal-
ized and internalized together. Interestingly, after 30 min at
37°C, the K1ITAM and K1C mutants (Fig. 10B and C) re-
mained bound together with BCR on the surface of the cells
and did not internalize, in contrast to K1WT and IgM, which
had been completely internalized at 30 min. By 60 min, the
majority of K1C and IgM remained on the surface, but the
majority of K1ITAM and IgM were internalized. These results
show that K1WT cointernalizes with the BCR.
DISCUSSION
It is well established that K1 is expressed on the cell surface
and activates signaling pathways, including the PI3K/Akt path-
way, through its C-terminal SH2 binding motifs that encode
the ITAM (21, 26, 45). In order to further elucidate the mech-
anism of K1 signaling, we have examined how its signaling
function at the plasma membrane is regulated. In this study, we
demonstrated that endocytosis and signaling of K1 are linked.
The two mutants, K1ITAM and K1C, show decreased inter-
nalization compared to K1WT and are partially internalized at
very late time points. At later time points, it is possible that the
FIG. 5. Amantadine inhibits K1 internalization. (A) Transfected HeLa cells were surface labeled with M1 anti-FLAG, and surface receptors
were allowed to internalize for 20 min in the presence or absence of drug. The amount of internalized antibody was quantified by ELISA. The data
are expressed as a ratio of the initial amount of antibody bound to the cell surface at zero minutes at 4°C to the amount of antibody bound in the
presence of drug. The error bars indicate standard deviations. (B) K1-expressing cells were surface labeled with anti-FLAG–Cy3 and anti-TfR–
Alexa 647 for 1 h at 4°C. The surface receptors were allowed to internalize at 37°C for 20 min in the presence of the drug. The cells were fixed
and analyzed by confocal microscopy.
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K1 mutants are being internalized nonspecifically. Thus, ele-
ments in the C terminus of K1 are required for efficient inter-
nalization, specifically, the ITAM motif. K1 has been shown to
activate Syk and PI3K signaling pathways, all of which are
dependent upon the ITAM of K1 (21, 25, 26, 45). Inhibiting K1
activation of PI3K and Syk kinase using LY294002 and piceat-
annol, respectively, resulted in decreased endocytosis of K1WT,
with little effect on the two mutants tested, further supporting
the role of signaling in the control of K1 surface expression.
We have also observed the reciprocal result; inhibiting inter-
nalization hinders efficient downstream signaling by K1.
In order to determine the mechanisms controlling K1 inter-
nalization, we analyzed the trafficking pattern of surface-la-
beled K1WT and mutants. Perturbing clathrin-dependent en-
docytosis markedly decreased the rate at which K1 was
internalized. We could inhibit K1 internalization by using a
dominant-negative clathrin hub, further supporting our data
that K1 is internalized via clathrin. Following internalization,
K1 was present in both early endosomes, since it colocalized
with EEA1, and in recycling endosomes, since it colocalized
with Rab11. Although the question of whether K1 is truly
recycled needs further investigation, it is an intriguing possi-
bility. Rab11 overexpression has been shown to facilitate the
transition of some proteins from early endosomes to late and
recycling endosomal compartments, but it does not drive mem-
brane proteins to the recycling endosome (11). Additionally, it
has been shown that the overexpression of WT Rab11 does not
cause a significant impairment in the capacity of the cells to
recycle transferrin molecules (37). Other viral glycoproteins,
such as the Us28 glycoprotein of cytomegalovirus (14), show
ligand-independent constitutive internalization and recycling.
Constitutive recycling may provide a convenient method for
the cell to regulate surface receptor numbers. If a rapid de-
crease in surface receptors is needed, the internalization rate
could be increased and/or recycling decreased, and vice versa.
In addition to receptor down-regulation, internalization of
receptor subunits also serves to modulate receptor signaling
pathways. Our laboratory has previously shown that K1 can
activate Akt via a PI3K-dependent pathway (45). Here, we
demonstrated that the ability of K1 to activate Akt kinase was
suppressed in cells in which endocytosis had been inhibited
(Fig. 9). The suppression of downstream signaling has been
shown for cellular receptors, as well. Using an internalization-
defective cell line, it was shown that EGF receptor (EGFR)-
mediated tyrosine phosphorylation and mitogen-activated
protein kinase activation were both attenuated in internaliza-
tion-defective cells (48). Further, correct trafficking of EGFR
is required to establish specific signaling pathways. Membrane
FIG. 6. Intracellular distribution of K1 and PI3K. (A) HeLa cells
were transfected with a K1WT expression plasmid. Forty-eight hours
posttransfection, the cells were surface labeled with anti-FLAG–Cy3 to
detect K1. After fixation and permeabilization, the cells were stained
using an anti-p85 primary antibody, followed by a FITC-conjugated
secondary antibody to detect the p85 subunit of PI3K. (B) Forty-eight
hours posttransfection, K1WT-expressing HeLa cells were fixed, per-
meabilized, and stained with anti-FLAG–Cy3 and anti-p85 primary
antibody, followed by a FITC-conjugated secondary antibody. The
cells were analyzed by confocal microscopy.
FIG. 7. Inhibition of K1 internalization by LY294002. (A) K1 in-
ternalization was measured in the presence or absence of LY294002.
Transfected HeLa cells were surface labeled with M1 anti-FLAG, and
surface receptors were allowed to internalize for 20 min in the pres-
ence of drug or vehicle control (dimethyl sulfoxide). The amount of
internalized antibody was quantified by ELISA as described in Mate-
rials and Methods. The data are expressed as a ratio of the initial
amount of antibody bound to the cell surface at 0 min at 4°C to the
amount of antibody bound in the presence of drug after the cells were
incubated at 37°C for 20 min. This is depicted as percent internaliza-
tion on the y axis. The error bars indicate standard deviations. (B) K1
internalization in the presence or absence of LY294002 as analyzed by
confocal microscopy. K1-expressing HeLa cells were surface labeled
with anti-FLAG–Cy3 and anti-TfR–Alexa 647 for 1 h at 4°C. The
surface receptors were allowed to internalize at 37°C for 0, 20, or 60
min in the presence of the drug. The cells were fixed and analyzed by
confocal microscopy.
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trafficking regulates the signal transduction events of EGFR.
There is also evidence that receptor tyrosine kinases signal
from endosomes. It has been demonstrated that the internal-
ized EGFR can still signal (7). EGFR remains bound to EGF
within the endosomal compartment; EGF-stimulated EGFRs
preserve their dimerization and their kinase activities within
endosomes (43, 52). Receptor signaling from endosomes might
allow spatial and temporal regulation of signal transduction.
Signal transduction could be compartmentalized at the plasma
membrane and on endosomes. Compartmentalization would
provide high flexibility to an otherwise limited number of
signaling cascades to transduce specific signals from multi-
ple signaling cues. There is, in fact, accumulating evidence
that signaling from endosomes could be used as a means to
compartmentalize signal transduction (40, 42).
The colocalization of K1 and the p85 subunit of PI3K is
consistent with models of PI3K function in which PI3K, a
principally cytoplasmic protein, is recruited to membranes
quantitatively in response to receptor activation. In cells in
which endocytosis is inhibited, the p85 subunit of PI3K is
hypophosphorylated (48). The endosomes are highly enriched
for PI3K activity.
Mutation of the K1 ITAM has previously been shown to
prevent phosphorylation, recruitment, and binding of Syk to
K1 (21, 25, 26). Specifically, K1’s ability to activate downstream
signaling was significantly reduced in Syk-deficient B cells (21).
Additionally, K1 signaling was shown to induce the phosphor-
ylation and activation of Syk kinase in B cells (21, 25, 26).
Furthermore, Syk kinase was also shown to bind to the doubly
phosphorylated K1 ITAM (21). Syk kinase can regulate Akt
activation through activation of PI3K (10, 15, 17, 31). Further,
it has been suggested that the activation of PI3K by Syk is
directly involved in endocytosis (22). Lee et al. (25) have shown
that K1 interacts with different signaling proteins through its
C-terminal tyrosine residues with different affinities. It is easy
to imagine that this differential phosphorylation of the tyrosine
residues in different locations in the cell, i.e., plasma mem-
brane versus endocytic vesicles, allows K1 to interact with
various cellular proteins. Indeed, several receptors can trans-
mit signals from endocytic compartments, and these signals
can be qualitatively different from those initiated at the plasma
membrane. For example, TrkA promotes nerve growth factor
(NGF)-mediated cell survival at the cell surface, whereas it
induces differentiation when internalized (53). Internalization
could couple activation with down-regulation, which allows
precise temporal control of signaling by limiting the lifetime of
the activated signaling components.
FIG. 8. Treatment of cells with piceatannol inhibits K1 internaliza-
tion. (A) HeLa cells were transfected with WT or mutant K1 expres-
sion plasmids for 48 hours. Transfected HeLa cells were then incu-
bated in the presence of 15 g/ml piceatannol. The cells were surface
labeled for K1. The amount of internalized receptor was quantified by
ELISA as described in Materials and Methods. The data are expressed
as a fraction of the initial amount of antibody bound to the cell surface
at 0 min at 4°C and are depicted as percent internalization on the y
axis. The error bars indicate standard deviations. (B) Confocal micros-
copy analysis of K1 internalization in the presence of piceatannol.
K1-expressing HeLa cells were surface labeled with anti-FLAG–Cy3
and anti-TfR–Alexa 647 for 1 h at 4°C. The surface receptors were
allowed to internalize at 37°C for 0, 20, or 60 min in the presence of the
drug. The cells were fixed and analyzed by confocal microscopy.
FIG. 9. Inhibition of clathrin-mediated endocytosis prevents K1 signaling. K1-expressing HeLa cells were treated with either amantadine or
hypertonic sucrose medium to inhibit clathrin or were left untreated for 30 min prior to harvesting of the cells. The lysates were subjected to
Western blot analysis. Equal amounts of proteins were separated by SDS-PAGE, transferred to nitrocellulose, and probed with phosphospecific
antibody to Akt S473 (top), stripped, and reprobed with antibody that recognized total Akt levels (bottom). No Tx, untreated cells.
VOL. 82, 2008 ENDOCYTOSIS AND SIGNALING OF THE KSHV K1 PROTEIN 6521
The fact that K1 cointernalizes with the BCR in B cells
suggests a physiologically important role for K1 internaliza-
tion. It is plausible that K1 may function to scavenge the BCR
from the surfaces of newly infected B cells.
In summary, the data presented in this report demonstrate
that K1 internalization occurs through a clathrin-mediated en-
docytic pathway. K1 protein expressed at the surface is consti-
tutively active and recruits PI3K to the membrane. Activation
of PI3K results in internalization of K1 via clathrin. Once
internalized, K1 continues to transduce signals, inducing the
activation of Akt and downstream signals. Inhibiting either
clathrin-dependent internalization or activation of PI3K pre-
vents efficient endocytosis and efficient signaling by K1. The
signaling of K1 at the plasma membrane is regulated by both
surface expression modulation and compartmentalized signal-
ing. This is yet an additional means for KSHV to control
cellular signaling pathways.
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